Citadel Advisors - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is and the CUSIP is 33830X954. A total of 3 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$364,000
-24.6%
8,800
-26.1%
0.00%
-100.0%
Q1 2016$483,000
+100.4%
11,900
+105.2%
0.00%
Q4 2015$241,0005,8000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 26,000$411,0000.00%
SIMPLEX TRADING, LLC 6$9,0000.00%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders